Skip to the content

FDA Medical Device Recalls (openFDA)

Beckman Coulter Inc.: Beckman Coulter Lipase, REF OSR6130 and OSR6230.

Recall number
Z-0210-2020
Recalling firm
Beckman Coulter Inc.
Product
Beckman Coulter Lipase, REF OSR6130 and OSR6230.
Status
Terminated
Initiated
2018-08-24
Posted
not on file
Terminated
2024-08-02
Reason
NAPQI, a metabolite of Acetaminophen, causes negative interference with the recalled product assays at levels present in the serum/plasma of overdose patients.
Root cause
Nonconforming Material/Component
Action
The recalling firm issued letters dated 8/21/2018 via email or postal mail if an email address was not available on 8/24/2018 to their customers. The letter identified the affected product, problem and actions to be taken. For questions call 1-800-223-0139 in the United States and Canada. Outside the United States and Canada contact local Beckman Coulter Representative.
Quantity
20,926 units
Distribution
Distribution was nationwide. There was government and military distribution. Foreign distribution was made to Canada.
Lot, serial or model codes
All lots
510(k) numbers
not on file
PMA numbers
not on file
Product code
CDT
Firm FEI
2050012
Firm city
Brea
Firm state
CA
Firm country
not on file

Where this comes from

Register
FDA Medical Device Recalls (openFDA)
Publisher
U.S. Food and Drug Administration (openFDA)
File
device-recall-0001-of-0001.json.zip
sha256
b87518bfe2e8
Size
288210821 bytes
Published
2026-09-28
Read
2026-09-29T08:25:23.626Z
Source file
Source file retained · verify
Refresh due
2026-10-06

Unless otherwise noted, the content, data, documentation, code, and related materials on openFDA is public domain and made available with a Creative Commons CC0 1.0 Universal dedication.

Cite as

FDA Medical Device Recalls (openFDA) (U.S. Food and Drug Administration (openFDA)), device-recall-0001-of-0001.json.zip, sha256 b87518bfe2e8, published 2026-09-28

Search this register